Resultats de la cerca - Haidar Maatouk

  • Mostrar 1 - 3 resultats de 3
Refinar resultats
  1. 1
    Pharmacokinetics and pharmacodynamics of ponesimod, a selective <scp>S1P<sub>1</sub></scp> receptor modulator, in the first‐in‐human study

    Pharmacokinetics and pharmacodynamics of ponesimod, a selective <scp>S1P<sub>1</sub></scp> receptor modulator, in the first‐in‐human study per Patrick Brossard, Hartmut Derendorf, Jian Xu, Haidar Maatouk, Atef Halabi, Jasper Dingemanse

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Multiple-dose tolerability, pharmacokinetics, and pharmacodynamics of ponesimod, an S1P<sub>1</sub>receptor modulator: Favorable impact of dose up-titration

    Multiple-dose tolerability, pharmacokinetics, and pharmacodynamics of ponesimod, an S1P<sub>1</sub>receptor modulator: Favorable impact of dose up-titration per Patrick Brossard, Michael W. Scherz, Atef Halabi, Haidar Maatouk, Andreas Krause, Jasper Dingemanse

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor

    Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor per Dagmar Kubitza, Michael Becka, Wolfgang Mueck, Atef Halabi, Haidar Maatouk, Norbert Klause, Volkmar Lufft, Dominic D. Wand, Thomas Philipp, Heike Bruck

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: